Experimental mRNA HIV vaccine safe, shows promise in animals
Published
An experimental HIV vaccine based on mRNA -- the same platform technology used in two highly effective COVID-19 vaccines -- shows promise in mice and non-human primates, according to scientists. Their results show that the novel vaccine was safe and prompted desired antibody and cellular immune responses against an HIV-like virus.
Full Article